02
May
2019
|
11:34
Europe/Amsterdam

CRISPRcon 2019 – Conversations on science, society and the future of gene editing

Summary

Meet us at CRISPRcon on June 20-21, and join the conversation on science, society and the future of gene editing. CRISPRcon creates a forum in which a broad selection of diverse voices come together. Will you join us?

CHIC photo 31

 

CRISPRcon 2019 is a program of Keystone Policy Center and will be hosted by our project coordinator Wageningen University & Research.

What is CRISPR-Cas?

CRISPR-Cas is a new technology that makes it possible to change genetic material from viruses, bacteria, cells, plants and animals in a relatively simple, very accurate and efficient way. This technology can make an enormous contribution to the quality of our environment, our health, agriculture and economy. At the same time there are concerns regarding ethical aspects, integrity of life, unfair distribution of property, security and who benefits.

What is our aim at CRISPRcon?

The aim of CRISPRcon is to stimulate open dialogue about precisely these aspects: exchanging opinions, visions and concerns. The conference is aimed at the largest possible cross-section of society. Wageningen University & Research hosts this dialogue and underlines the importance of an open dialogue about the CRISPR technique. At the event, you can join sessions on several aspects of gene editing.

Sessions:

Panel 1: Personal Reflections: The Promise and Perils of Gene EditingPanel 2: CRISPR Cures: Gene Editing in Personal and Public HealthPanel 3: The Evolution of Innovation: What Drives Societal Embrace or Rejection of Emerging Technologies?Panel 4: Growing for Good?: Gene Editing and AgriculturePanel 5: Double Helixes and the Circular Economy: Gene Editing and Environmental StewardshipPanel 6: With Great Power Comes Great Responsibility: Globalization, Governance and Power

More about speakers, programme and registration:

crisprcon.org/crisprcon-2019

szkic_Dirk_b

About CHIC Project

CHIC is the Chicory Innovation Consortium. Its objective is to implement New Plant Breeding Techniques (NPBTs) in chicory in order to establish it as a multipurpose crop for the production of health-related products with clear benefits for consumers and to develop co-innovation pathways with stakeholders for game-changing technologies, such as NPBTs. CHIC will develop four different NPBTs. They will be used to steer bioprocesses in chicory and mobilize its under-explored potential to produce immunomodulatory prebiotics and medicinal terpenes. The conceptually different NPBTs will be assessed with respect to technological potential, risks, regulatory framework, and their socio-economic impacts. This will be done in close consultation with a Stakeholder Advisory Group (SAG) composed of relevant stakeholders in industry and society. For more information, visit our website at chicproject.eu/